A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma

Karin A W Wadt, L. G. Aoude, P. Johansson, A. Solinas, A. Pritchard, O. Crainic, M. T. Andersen, J. F. Kiilgaard, S. Heegaard, L. Sunde, B. Federspiel, J. Madore, J. F. Thompson, S. W. Mccarthy, A. Goodwin, H. Tsao, G. Jönsson, K. Busam, R. Gupta, J. M. TrentA. M. Gerdes, K. M. Brown, R. A. Scolyer, N. K. Hayward

Research output: Contribution to journalArticle

Abstract

We report four previously undescribed families with germline BRCA1-associated protein-1 gene (BAP1) mutations and expand the clinical phenotype of this tumor syndrome. The tumor spectrum in these families is predominantly uveal malignant melanoma (UMM), cutaneous malignant melanoma (CMM) and mesothelioma, as previously reported for germline BAP1 mutations. However, mutation carriers from three new families, and one previously reported family, developed basal cell carcinoma (BCC), thus suggesting inclusion of BCC in the phenotypic spectrum of the BAP1 tumor syndrome. This notion is supported by the finding of loss of BAP1 protein expression by immunochemistry in two BCCs from individuals with germline BAP1 mutations and no loss of BAP1 staining in 53 of sporadic BCCs consistent with somatic mutations and loss of heterozygosity of the gene in the BCCs occurring in mutation carriers. Lastly, we identify the first reported recurrent mutation in BAP1 (p.R60X), which occurred in three families from two different continents. In two of the families, the mutation was inherited from a common founder but it arose independently in the third family.

Original languageEnglish (US)
Pages (from-to)267-272
Number of pages6
JournalClinical Genetics
Volume88
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

BRCA1 Protein
Basal Cell Carcinoma
Mutation
Genes
Neoplasms
Immunochemistry
Loss of Heterozygosity
Melanoma
Staining and Labeling
Phenotype
Gene Expression

Keywords

  • BAP1
  • BCC
  • Cancer predisposition syndrome
  • Germline mutation
  • Melanoma
  • Unknown primary tumor

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Wadt, K. A. W., Aoude, L. G., Johansson, P., Solinas, A., Pritchard, A., Crainic, O., ... Hayward, N. K. (2015). A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clinical Genetics, 88(3), 267-272. https://doi.org/10.1111/cge.12501

A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. / Wadt, Karin A W; Aoude, L. G.; Johansson, P.; Solinas, A.; Pritchard, A.; Crainic, O.; Andersen, M. T.; Kiilgaard, J. F.; Heegaard, S.; Sunde, L.; Federspiel, B.; Madore, J.; Thompson, J. F.; Mccarthy, S. W.; Goodwin, A.; Tsao, H.; Jönsson, G.; Busam, K.; Gupta, R.; Trent, J. M.; Gerdes, A. M.; Brown, K. M.; Scolyer, R. A.; Hayward, N. K.

In: Clinical Genetics, Vol. 88, No. 3, 01.09.2015, p. 267-272.

Research output: Contribution to journalArticle

Wadt, KAW, Aoude, LG, Johansson, P, Solinas, A, Pritchard, A, Crainic, O, Andersen, MT, Kiilgaard, JF, Heegaard, S, Sunde, L, Federspiel, B, Madore, J, Thompson, JF, Mccarthy, SW, Goodwin, A, Tsao, H, Jönsson, G, Busam, K, Gupta, R, Trent, JM, Gerdes, AM, Brown, KM, Scolyer, RA & Hayward, NK 2015, 'A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma', Clinical Genetics, vol. 88, no. 3, pp. 267-272. https://doi.org/10.1111/cge.12501
Wadt, Karin A W ; Aoude, L. G. ; Johansson, P. ; Solinas, A. ; Pritchard, A. ; Crainic, O. ; Andersen, M. T. ; Kiilgaard, J. F. ; Heegaard, S. ; Sunde, L. ; Federspiel, B. ; Madore, J. ; Thompson, J. F. ; Mccarthy, S. W. ; Goodwin, A. ; Tsao, H. ; Jönsson, G. ; Busam, K. ; Gupta, R. ; Trent, J. M. ; Gerdes, A. M. ; Brown, K. M. ; Scolyer, R. A. ; Hayward, N. K. / A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. In: Clinical Genetics. 2015 ; Vol. 88, No. 3. pp. 267-272.
@article{0be55f312e16424782bbeac41f46d629,
title = "A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma",
abstract = "We report four previously undescribed families with germline BRCA1-associated protein-1 gene (BAP1) mutations and expand the clinical phenotype of this tumor syndrome. The tumor spectrum in these families is predominantly uveal malignant melanoma (UMM), cutaneous malignant melanoma (CMM) and mesothelioma, as previously reported for germline BAP1 mutations. However, mutation carriers from three new families, and one previously reported family, developed basal cell carcinoma (BCC), thus suggesting inclusion of BCC in the phenotypic spectrum of the BAP1 tumor syndrome. This notion is supported by the finding of loss of BAP1 protein expression by immunochemistry in two BCCs from individuals with germline BAP1 mutations and no loss of BAP1 staining in 53 of sporadic BCCs consistent with somatic mutations and loss of heterozygosity of the gene in the BCCs occurring in mutation carriers. Lastly, we identify the first reported recurrent mutation in BAP1 (p.R60X), which occurred in three families from two different continents. In two of the families, the mutation was inherited from a common founder but it arose independently in the third family.",
keywords = "BAP1, BCC, Cancer predisposition syndrome, Germline mutation, Melanoma, Unknown primary tumor",
author = "Wadt, {Karin A W} and Aoude, {L. G.} and P. Johansson and A. Solinas and A. Pritchard and O. Crainic and Andersen, {M. T.} and Kiilgaard, {J. F.} and S. Heegaard and L. Sunde and B. Federspiel and J. Madore and Thompson, {J. F.} and Mccarthy, {S. W.} and A. Goodwin and H. Tsao and G. J{\"o}nsson and K. Busam and R. Gupta and Trent, {J. M.} and Gerdes, {A. M.} and Brown, {K. M.} and Scolyer, {R. A.} and Hayward, {N. K.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1111/cge.12501",
language = "English (US)",
volume = "88",
pages = "267--272",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma

AU - Wadt, Karin A W

AU - Aoude, L. G.

AU - Johansson, P.

AU - Solinas, A.

AU - Pritchard, A.

AU - Crainic, O.

AU - Andersen, M. T.

AU - Kiilgaard, J. F.

AU - Heegaard, S.

AU - Sunde, L.

AU - Federspiel, B.

AU - Madore, J.

AU - Thompson, J. F.

AU - Mccarthy, S. W.

AU - Goodwin, A.

AU - Tsao, H.

AU - Jönsson, G.

AU - Busam, K.

AU - Gupta, R.

AU - Trent, J. M.

AU - Gerdes, A. M.

AU - Brown, K. M.

AU - Scolyer, R. A.

AU - Hayward, N. K.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - We report four previously undescribed families with germline BRCA1-associated protein-1 gene (BAP1) mutations and expand the clinical phenotype of this tumor syndrome. The tumor spectrum in these families is predominantly uveal malignant melanoma (UMM), cutaneous malignant melanoma (CMM) and mesothelioma, as previously reported for germline BAP1 mutations. However, mutation carriers from three new families, and one previously reported family, developed basal cell carcinoma (BCC), thus suggesting inclusion of BCC in the phenotypic spectrum of the BAP1 tumor syndrome. This notion is supported by the finding of loss of BAP1 protein expression by immunochemistry in two BCCs from individuals with germline BAP1 mutations and no loss of BAP1 staining in 53 of sporadic BCCs consistent with somatic mutations and loss of heterozygosity of the gene in the BCCs occurring in mutation carriers. Lastly, we identify the first reported recurrent mutation in BAP1 (p.R60X), which occurred in three families from two different continents. In two of the families, the mutation was inherited from a common founder but it arose independently in the third family.

AB - We report four previously undescribed families with germline BRCA1-associated protein-1 gene (BAP1) mutations and expand the clinical phenotype of this tumor syndrome. The tumor spectrum in these families is predominantly uveal malignant melanoma (UMM), cutaneous malignant melanoma (CMM) and mesothelioma, as previously reported for germline BAP1 mutations. However, mutation carriers from three new families, and one previously reported family, developed basal cell carcinoma (BCC), thus suggesting inclusion of BCC in the phenotypic spectrum of the BAP1 tumor syndrome. This notion is supported by the finding of loss of BAP1 protein expression by immunochemistry in two BCCs from individuals with germline BAP1 mutations and no loss of BAP1 staining in 53 of sporadic BCCs consistent with somatic mutations and loss of heterozygosity of the gene in the BCCs occurring in mutation carriers. Lastly, we identify the first reported recurrent mutation in BAP1 (p.R60X), which occurred in three families from two different continents. In two of the families, the mutation was inherited from a common founder but it arose independently in the third family.

KW - BAP1

KW - BCC

KW - Cancer predisposition syndrome

KW - Germline mutation

KW - Melanoma

KW - Unknown primary tumor

UR - http://www.scopus.com/inward/record.url?scp=84938844516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938844516&partnerID=8YFLogxK

U2 - 10.1111/cge.12501

DO - 10.1111/cge.12501

M3 - Article

C2 - 25225168

AN - SCOPUS:84938844516

VL - 88

SP - 267

EP - 272

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 3

ER -